ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.000
-0.050 (-2.44%)
Aug 28, 2026, 4:00 PM EDT - Market closed
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $276.55 million as of August 28, 2026. Its market cap has increased by 330.36% in one year.
Market Cap
276.55M
Enterprise Value
149.36M
1-Year Change
330.36%
Ranking
Category
Stock Price
$2.00
ChartMarket Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $276.55M, a decrease of -73.82%. That is a compound annual growth rate of -19.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 276.55M | 351.40% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 291.16M |
| Cartesian Therapeutics | 290.45M |
| Invivyd | 284.29M |
| Lineage Cell Therapeutics | 280.73M |
| Anavex Life Sciences | 277.16M |
| Pyxis Oncology | 269.41M |
| Sionna Therapeutics | 265.40M |
| Surrozen | 263.51M |